InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the detailed record of transactions filed by Gregory Philip D, Directeur Scientifique. Director active across 2 companies, notably bluebird bio, Inc.. Aggregated, 11 disclosures have been recorded. Total volume traded: €63k. The latest transaction was disclosed on 1 March 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations11 total
047,500 shares0
Common Stock
SEC:0001562180-22-003846:0·
€30,7291,452 shares@ €21.163250.0% of flow
Common Stock
SEC:0001562180-22-000410:0·
€30,7291,452 shares@ €21.1632100.0% of flow
Common Stock
SEC:0001562180-22-000410·
02,092 shares0
Common Stock
SEC:0001628280-21-023653·
02,092 shares0
Common Stock
SEC:0001628280-21-023653:0·
0697 shares0
Common Stock
SEC:0001628280-21-023467·
0697 shares0
Common Stock
SEC:0001628280-21-023467:0·
033,927 shares0
Common Stock
SEC:0001562180-21-005175·
033,927 shares0
Common Stock
SEC:0001562180-21-005175:0·
€97539 shares@ €24.9983100.0% of flow
Common Stock
SEC:0001562180-21-003232·
€97539 shares@ €24.998350.0% of flow
Common Stock
SEC:0001562180-21-003232:0·
11 of 11 declarations
About Gregory Philip D
Philip D. Gregory is the Chief Scientific Officer at bluebird bio, Inc. and 2seventy bio, Inc. He leads research and development efforts focused on innovation in biotechnology. His scientific expertise is crucial for the development of new therapies and medical solutions.
